Last reviewed · How we verify
Determination of blood drug concentration
Determination of blood drug concentration is a Biologic drug developed by Beijing Anzhen Hospital. It is currently FDA-approved.
At a glance
| Generic name | Determination of blood drug concentration |
|---|---|
| Sponsor | Beijing Anzhen Hospital |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population
- Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide (PHASE1)
- Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage
- General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia (NA)
- Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects
- Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP (NA)
- Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions (NA)
- Physical Activity and Insulin Sensitivity Dynamics (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Determination of blood drug concentration CI brief — competitive landscape report
- Determination of blood drug concentration updates RSS · CI watch RSS
- Beijing Anzhen Hospital portfolio CI
Frequently asked questions about Determination of blood drug concentration
What is Determination of blood drug concentration?
Determination of blood drug concentration is a Biologic drug developed by Beijing Anzhen Hospital.
Who makes Determination of blood drug concentration?
Determination of blood drug concentration is developed and marketed by Beijing Anzhen Hospital (see full Beijing Anzhen Hospital pipeline at /company/beijing-anzhen-hospital).
What development phase is Determination of blood drug concentration in?
Determination of blood drug concentration is FDA-approved (marketed).